365 related articles for article (PubMed ID: 15735050)
21. Estrogen receptor signaling pathways in human non-small cell lung cancer.
Márquez-Garbán DC; Chen HW; Fishbein MC; Goodglick L; Pietras RJ
Steroids; 2007 Feb; 72(2):135-43. PubMed ID: 17276470
[TBL] [Abstract][Full Text] [Related]
22. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors.
Klinge CM; Jernigan SC; Mattingly KA; Risinger KE; Zhang J
J Mol Endocrinol; 2004 Oct; 33(2):387-410. PubMed ID: 15525597
[TBL] [Abstract][Full Text] [Related]
23. Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-alpha and estrogen receptor-beta: correlations with biological character and distinct differences among SRC coactivator family members.
Kraichely DM; Sun J; Katzenellenbogen JA; Katzenellenbogen BS
Endocrinology; 2000 Oct; 141(10):3534-45. PubMed ID: 11014206
[TBL] [Abstract][Full Text] [Related]
24. Estradiol repression of tumor necrosis factor-alpha transcription requires estrogen receptor activation function-2 and is enhanced by coactivators.
An J; Ribeiro RC; Webb P; Gustafsson JA; Kushner PJ; Baxter JD; Leitman DC
Proc Natl Acad Sci U S A; 1999 Dec; 96(26):15161-6. PubMed ID: 10611355
[TBL] [Abstract][Full Text] [Related]
25. Disruption of 3D MCF-12A breast cell cultures by estrogens--an in vitro model for ER-mediated changes indicative of hormonal carcinogenesis.
Marchese S; Silva E
PLoS One; 2012; 7(10):e45767. PubMed ID: 23056216
[TBL] [Abstract][Full Text] [Related]
26. Isoform-selective interactions between estrogen receptors and steroid receptor coactivators promoted by estradiol and ErbB-2 signaling in living cells.
Bai Y; Giguére V
Mol Endocrinol; 2003 Apr; 17(4):589-99. PubMed ID: 12554772
[TBL] [Abstract][Full Text] [Related]
27. Regulation of ERRalpha gene expression by estrogen receptor agonists and antagonists in SKBR3 breast cancer cells: differential molecular mechanisms mediated by g protein-coupled receptor GPR30/GPER-1.
Li Y; Birnbaumer L; Teng CT
Mol Endocrinol; 2010 May; 24(5):969-80. PubMed ID: 20211987
[TBL] [Abstract][Full Text] [Related]
28. Molecular mechanisms of selective estrogen receptor modulator activity in human breast cancer cells: identification of novel nuclear cofactors of antiestrogen-ERα complexes by interaction proteomics.
Cirillo F; Nassa G; Tarallo R; Stellato C; De Filippo MR; Ambrosino C; Baumann M; Nyman TA; Weisz A
J Proteome Res; 2013 Jan; 12(1):421-31. PubMed ID: 23170835
[TBL] [Abstract][Full Text] [Related]
29. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
Gougelet A; Mueller SO; Korach KS; Renoir JM
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):110-22. PubMed ID: 17478088
[TBL] [Abstract][Full Text] [Related]
30. Hypoxia reduces hormone responsiveness of human breast cancer cells.
Kurebayashi J; Otsuki T; Moriya T; Sonoo H
Jpn J Cancer Res; 2001 Oct; 92(10):1093-101. PubMed ID: 11676860
[TBL] [Abstract][Full Text] [Related]
31. Bisphenol A and estrogen induce proliferation of human thyroid tumor cells via an estrogen-receptor-dependent pathway.
Zhang Y; Wei F; Zhang J; Hao L; Jiang J; Dang L; Mei D; Fan S; Yu Y; Jiang L
Arch Biochem Biophys; 2017 Nov; 633():29-39. PubMed ID: 28882636
[TBL] [Abstract][Full Text] [Related]
32. Estrogen receptor-alpha-interacting cytokeratins potentiate the antiestrogenic activity of fulvestrant.
Long X; Fan M; Nephew KP
Cancer Biol Ther; 2010 Mar; 9(5):389-96. PubMed ID: 20061804
[TBL] [Abstract][Full Text] [Related]
33. Fulvestrant-mediated inhibition of estrogen receptor signaling slows lung cancer progression.
Tang H; Liao Y; Zhang C; Chen G; Xu L; Liu Z; Fu S; Yu L; Zhou S
Oncol Res; 2014; 22(1):13-20. PubMed ID: 25700354
[TBL] [Abstract][Full Text] [Related]
34. Cooperative activation of gene expression by agonists and antagonists mediated by estrogen receptor heteroligand dimer complexes.
Liu S; Han SJ; Smith CL
Mol Pharmacol; 2013 May; 83(5):1066-77. PubMed ID: 23462505
[TBL] [Abstract][Full Text] [Related]
35. Activation of the human estrogen receptor by the antiestrogens ICI 182,780 and tamoxifen in yeast genetic systems: implications for their mechanism of action.
Dudley MW; Sheeler CQ; Wang H; Khan S
Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3696-701. PubMed ID: 10725345
[TBL] [Abstract][Full Text] [Related]
36. Distinct effects on the conformation of estrogen receptor alpha and beta by both the antiestrogens ICI 164,384 and ICI 182,780 leading to opposite effects on receptor stability.
Van Den Bemd GJ; Kuiper GG; Pols HA; Van Leeuwen JP
Biochem Biophys Res Commun; 1999 Jul; 261(1):1-5. PubMed ID: 10405313
[TBL] [Abstract][Full Text] [Related]
37. Regulation of estrogen receptor (ER) isoform messenger RNA expression by different ER ligands in female rat pituitary.
Tena-Sempere M; Navarro VM; Mayen A; Bellido C; Sánchez-Criado JE
Biol Reprod; 2004 Mar; 70(3):671-8. PubMed ID: 14613904
[TBL] [Abstract][Full Text] [Related]
38. Terpenoids found in the umbelliferae family act as agonists/antagonists for ER(alpha) and ERbeta: differential transcription activity between ferutinine-liganded ER(alpha) and ERbeta.
Ikeda K; Arao Y; Otsuka H; Nomoto S; Horiguchi H; Kato S; Kayama F
Biochem Biophys Res Commun; 2002 Feb; 291(2):354-60. PubMed ID: 11846412
[TBL] [Abstract][Full Text] [Related]
39. Estrogen responses in bovine fetal uterine cells involve pathways directed by both estrogen response element and activator protein-1.
Malayer JR; Cheng J; Woods VM
Biol Reprod; 1999 May; 60(5):1204-10. PubMed ID: 10208985
[TBL] [Abstract][Full Text] [Related]
40. Ligands differentially modulate the protein interactions of the human estrogen receptors alpha and beta.
Margeat E; Bourdoncle A; Margueron R; Poujol N; Cavaillès V; Royer C
J Mol Biol; 2003 Feb; 326(1):77-92. PubMed ID: 12547192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
